Cancer Research
-
IU Study July 2026: Faster Bowel Cancer Treatment Urged
BLOOMINGTON, July 15 — Researchers at the Indiana University School of Medicine have published a study that cuts through the usual clinical…
-
Timely treatment key in under-50 bowel cancer cases
INDIANAPOLIS, July 15 — A study published yesterday by researchers at the Indiana University School of Medicine is bringing new urgency to…
-
Bowel Cancer Delay Over 45 Days Raises Metastasis Risk 55%
INDIANAPOLIS, July 15 — The shift in bowel cancer treatment is no longer just about detecting it early. A new study from…
-
Largest U.S. study links marijuana use to lung cancer risk
WASHINGTON, July 15 — A new case-control study, the largest of its kind ever conducted in the United States, has delivered a…
-
Ernexa Therapeutics Advances Cancer Therapy Candidate to Phase 1 Trials
SAN FRANCISCO, July 15 — Ernexa Therapeutics, a biotechnology company operating in the U.S. healthcare sector, is preparing to advance its lead…
-
ERNA-101 Platform Targets Cancer with Differentiated Therapy
NEW YORK, July 15 — A new targeted cancer therapy platform is moving toward its first human trials, offering a potential advance…
-
Ernexa Therapeutics targets 2026 for first-in-human cancer trial
NEW YORK, July 15 — Ernexa Therapeutics is moving its lead candidate ERNA-101 toward a first-in-human Phase 1 study, with the trial…
-
Delays in chemo before surgery risky for bowel cancer patients
INDIANAPOLIS, July 15 — A new study from the Indiana University School of Medicine has shed light on a critical window of…
-
Ernexa Therapeutics Advances ERNA-101 to First-in-Human Trial Planning
SINGAPORE, July 15 — A new cancer therapy candidate is taking its first step from the laboratory bench toward the bedside, with…
-
Akeso’s Cadonilimab Enters U.S. Phase II Trial After FDA Clearance
BEIJING, July 15 — Akeso’s experimental cancer drug cadonilimab is now being studied in a Phase II clinical trial in the United…
-
Akeso’s Cadonilimab trial expands into US for new cancer treatment
ISLAMABAD, July 15 — Akeso, the Chinese biopharmaceutical company, has advanced its investigational drug cadonilimab into a Phase II clinical trial in…
-
Pioneering pharmacologist honored for breast cancer breakthrough
WASHINGTON, July 15 — V. Craig Jordan, the British-American pharmacologist whose work turned tamoxifen into a cornerstone of hormone-positive breast cancer therapy,…
-
Routine screening for uterine cancer in asymptomatic tamoxifen users remains unadvised
ISLAMABAD, July 15 — For millions of women worldwide, tamoxifen has been a cornerstone of breast cancer treatment and prevention for decades.…
-
CAR-T Therapy Shows 83% Remission in Late-Stage Blood Cancer Trial
HOUSTON, July 14 — On the ground at MD Anderson Cancer Center, doctors are watching a new weapon against leukemia unfold. A…
-
FDA Warns 45 Percent of CAR-T Trial Patients Had Cytokine Storm
WASHINGTON, July 14 — A June 2024 clinical trial for the investigational CAR-T therapy CTX-112 recorded cytokine release syndrome in 45 percent…
-
Immunotherapy harnesses immune system to fight cancer tumors
NEW YORK, July 14 — When James Allison and Tasuku Honjo shared the Nobel Prize in Physiology or Medicine in 2018, they…
-
Theo Burrell’s death sparks renewed calls for brain cancer research funding
LONDON, July 14 — Theo Burrell’s four-year battle with brain cancer ended at age 39, and her death has prompted renewed calls…
-
From HIV Research to a Living Drug: Carl June’s CAR-T Breakthrough
PHILADELPHIA, July 14 — The man who rewrote the rules of cancer immunotherapy never set out to be a revolutionary. Carl June,…
-
McGill University leads as hub for cancer clinical trials
MONTREAL, July 13 — McGill University has announced a new partnership with HDT Bio, a biotechnology firm, to advance clinical trials for…
-
HDT Bio launches brain cancer clinical program with RNA technology
MONTREAL, July 13 — HDT Bio Corp., a biotechnology firm known for its work in RNA-based vaccines and therapies, is expanding into…
-
Brain Cancer Statistics: The Urgent Need for New Treatments
WASHINGTON, July 13 — The diagnosis arrives like a door slamming shut. For the roughly 25,000 Americans who learn each year they…
-
AI Matches or Outperforms Standard Genomic Recurrence Tests
NEW YORK, July 12 — A new AI tool from New York University may offer a cheaper alternative to genomic tests for…
-
Vaccines and Immunotherapy Harness Immune System to Fight Disease
ISLAMABAD, July 10 — Vaccines and immunotherapies are transforming how medicine approaches both prevention and treatment, with a growing body of evidence…
-
FDA Approves Eight New Immunotherapies in 2022 Alone
WASHINGTON, July 10 — The first checkpoint inhibitor landed in March 2011, a drug called ipilimumab, approved for melanoma. Since then, the…
Most read
-
Minnesota Makes Personal Finance Course Mandatory for High School Graduation
-
UK Households With £10,000 Risk Losing £300 To Low Interest Rates
-
Selangor International Care Expo in Kuala Lumpur 2026
-
Asian & Oceanian Epilepsy Congress 2026 in Kuala Lumpur
-
Baby & Beyond Maternity Expo in Kuala Lumpur 2026
-
Legal Battles Over Cancer Funding Delay Life-Saving Care for Patients
-
Stanford Digital Twins Identify Drug Combo To Stop Premature Birth
-
Why Microsatellite Instability Status Dictates Rectal Cancer Treatment Choices
-
Why KRAS Was Considered Undruggable for Decades and What Finally Cracked It
-
Why Long COVID Raises Hypertension Risk and How to Monitor Your Blood Pressure
-
How Private Credit Facilities Expand Access to Affordable Consumer Lending
-
Nationwide Rate Boost: How Rising Cash ISA Yields Beat Inflation Without Long-Term Lock-Ins
-
Estate Taxes Hit Retirees Selling High-Value Art: Navigating Double Taxation Risks
-
How Revolving Credit Card Balances Drive Industry Profits and Stifle Budgets
-
Why Medicare Documentation Rules Drive Denied Claims for Diabetic Shoes
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Dennis Lo Pioneers Liquid Biopsy for Cancer and Prenatal Testing
-
New Research Highlights Rising Internet Addiction Debate
-
Study Suggests Drinking Water With Meals May Lead To Overeating
-
Real-World Oncotype DX Adoption: Rates and Key Challenges
-
Energy Drinks: Youth Marketing, Caffeine Risks Under Scrutiny
-
ADHD Dopamine Dysfunction Disrupts Sleep-Wake Cycles, Study Finds